Kristen McCullough

机构：Mayo Clinic, Mayo Clinic in Arizona · ORCID：0000-0003-4252-2619

发表论文 121 篇 · 总被引 1867 次 · h-index 24

代表论文

Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent (2024 · American Journal of Hematology · 被引 31)
High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations (2024 · Blood · 被引 14)
The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance (2024 · Blood Advances · 被引 8)
Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent (2024 · Haematologica · 被引 5)
Venetoclax in combination with fludarabine, cytarabine, granulocyte colony stimulating factor, and idarubicin (FLAG-Ida) in patients with acute leukemia of ambiguous lineage and acute lymphoblastic leukemia (2025 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 4)
Phase II Trial Assessing Safety and Preliminary Efficacy of High-Dose Intravenous Ascorbic Acid and Decitabine in TET2 -Mutant Chronic Myelomonocytic Leukemia (2024 · Blood · 被引 3)